Език: EN EN
← Назад към резултатите
Активно (без набиране) Не е приложимо NCT04428944

STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

Не е приложима фаза (напр. обсервационно)
Заболявания: Atrial Fibrillation

Спонсор: McGill University Health Centre/Research Institute of the McGill University Health Centre

Налично на: БГ
Обобщение
The objective of this study is to compare the efficacy of three different ablation strategies in patients with persistent AF: 1. PV antral isolation alone (PVAI) 2. PV antral isolation plus ablation of drivers (PVAI+drivers) 3. PV antral isolation plus isolation of posterior wall (PVAI+box) All three strategies will employ contemporary catheter ablation technology using more efficient open irrigated tip cooling and contact force sensing.
Кой може да участва
Inclusion Criteria: 1. Patients 18 years of age or older 2. Patients undergoing first-time ablation procedure for AF 3. Patients with persistent AF defined as a sustained episode more than 3 months but less than three years 4. Patients with symptomatic AF - symptomatic patients are those who have been aware of their AF at any time within the last 5 years prior to enrolment. Symptoms may include, but are not restricted to, palpitations, shortness of breath, chest pain, fatigue, left ventricular dysfunction, or other symptoms or any combination of the above 5. Patients whose AF has been refractory to at least one antiarrhythmic drug 6. At least one episode of AF must have been documented by ECG, holter, loop recorder, telemetry, trans-telephonic monitor or implanted device within the last 2 years from enrolment 7. Patients must be able and willing to provide written informed consent to participate in the study Exclusion Criteria: 1. Patients with paroxysmal AF (no episodes lasting \> 7 days) 2. Patients with early persistent AF, sustained episode ≤ 3 months 3. Patients with very long lasting persistent AF (episodes lasting \> 3 years) 4. Patients with CHA2DS2-VASc score of 0. 5. Patients for whom cardioversion or sinus rhythm will never be attempted/pursued 6. Patients with AF felt to be secondary to an obvious reversible cause 7. Patients with contraindication to oral anticoagulation or systemic anticoagulation with heparin 8. Patients with left atrial diameter \> 60 mm in the parasternal long axis view 9. Patients who are pregnant
Места на провеждане 8
Австралия (1)
Canberra Heart Rhythm Foundation
Garran , Australian Capital Territory
Белгия (1)
OLV Hospital Aalst
Aalst
Канада (1)
University of Calgary Foothills
Calgary , Alberta
Франция (1)
Hospital St-Joseph
Marseille
Италия (1)
Ospedale Generale Regionale F. Miulli
Acquaviva delle Fonti
Япония (1)
Dokkyo Medical University Koshigaya Hospital
Koshigaya , Saitama
Испания (1)
Hospital Clinic Barcelona
Barcelona
САЩ (1)
Brigham & Women'S Hosptial Inc.
Boston , Massachusetts
Технически детайли
Статус
Активно (без набиране)
Фаза
Не е приложимо
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Здрави доброволци
Не
Начална дата
01.06.2021
Крайна дата
01.12.2027
Регистрационен номер
NCT04428944
Източник
anzctr
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.